Pro 2013-013 (Announcement of Jianfeng Group on Mutual Insurance with Kane)
Release time:
2020-08-05
Securities Code: 600668 Securities abbreviation: Sharp Group No: pro 2013-013
Announcement of Zhejiang Jianfeng Group Co., Ltd. on Mutual Guarantee between
and Zhejiang Kane Special Materials Co., Ltd.
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Reminder
● Name of Guarantor: Zhejiang Kane Special Materials Co., Ltd. (hereinafter referred to as Kane Stock)
● Quantity of this guarantee: RMB 50 million Yuan
● Is there any counter-guarantee for this guarantee: this guarantee is subject to equal mutual insurance
● Cumulative number of overdue external guarantees: no
Overview of 1. guarantees
On April 19, 2013, Zhejiang Jianfeng Group Co., Ltd. held the 10th meeting of the 8th Board of Directors. Nine directors should be present at the meeting. Independent director Deng Mingran entrusted independent director Liu Jiajian to attend the meeting due to official business. The remaining eight directors attended the meeting in person; they complied with the relevant provisions of the "Company Law" and the "Articles of Association", and the resolutions made were legal and effective. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the proposal of mutual guarantee with Zhejiang Kane Special Materials Co., Ltd. was deliberated and passed with 9 votes in favor, 0 against and 0 abstention.
agreed to implement a mutual guarantee with Kane shares of 50 million yuan for a period of one year. The external guarantee matters shall be submitted to the general meeting of shareholders for consideration and approval before implementation.
Basic information of the 2. guarantor
1. Name of the guarantor: Zhejiang Kane Special Materials Co., Ltd.
2, date of establishment: January 23, 1998 .
3. Listing: Listed on Shenzhen Stock Exchange on July 5, 2004, stock code: 002012.
4. Domicile: 1008 Kane Road, Suichang County, Zhejiang Province.
5, registered capital: 46762 . 5 50000 yuan. Legal representative: Ji Hao.
6. Business scope: manufacturing, processing and sales of electronic materials, paper and paper products; papermaking raw materials, etc.
7. Relationship with the Company: There is no relationship with the Company. Financial situation of
Kane shares: as of the end of 201 , the audited total assets were 1611.3942 million yuan, the total liabilities were 83 41689 . 66 yuan, and the total owner's equity attributable to the parent company was 111924 . 9 80000 yuan. In 201 , operating income 86391 . 87 yuan, net profit 8598 . 1 50000 yuan. The main contents of
3. guarantee
company plans to carry out mutual guarantee with Kane shares in an amount of 50 million yuan for a period of one year. Kane shares held the 28th meeting of the fifth board of directors on March 22, 2013, and reviewed and approved the "Proposal on Mutual Guarantee with Zhejiang Jianfeng Group Co., Ltd.", Kane shares held on April 17, 2013 The 2012 annual general meeting of shareholders has approved the proposal.
4. Board of Directors Opinion
Kane shares are listed companies with transparent financial information, good operating performance and the ability to repay debts. The board of directors agrees to carry out mutual insurance with them. The three independent directors of the company issued an independent opinion that was expressly agreed.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 670 million yuan, accounting for 44.22 of the total owner's equity attributable to the parent company in 2012. The total amount of guarantee approved by the company to the holding subsidiary is 730 million yuan, accounting for 48.18 of the total owner's equity attributable to the parent company in 2012.
As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries was 70 million yuan, accounting for 4.62 of the total owner's equity attributable to the parent company by the audited consolidated caliber in 2012; The actual balance of the company's guarantee to the holding subsidiary is 206.37 million yuan, accounting for 13.62 of the total owner's equity attributable to the parent company by the audited consolidated caliber in 2012.
As of the disclosure date of this announcement, the company has no overdue guarantee.
6. Reference Document Catalogue
1 , Resolution of the Tenth Meeting of the Eighth Board of Directors of the Company;
2 , copy of the business license of the guarantor;
hereby announces
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 23, 2013
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31